EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 22-Jun-2026 14:16 ET (22-Jun-2026 18:16 GMT/UTC)

15-Apr-2026

LRRC8A - a multifaceted regulator in human pathologies

Compuscript Ltd
Peer-Reviewed Publication

Leucine-rich repeat-containing 8A (LRRC8A) is a ubiquitously expressed transmembrane protein that functions as the essential component of volume-regulated anion channels (VRACs). These channels are integral to maintaining osmotic balance, metabolite transport, and intercellular communication, thereby ensuring ion homeostasis and facilitating cellular responses to hypotonic stress, oxidative damage, and mechanical cues.

Journal: Genes & Diseases
Funder: Key Research and Development Projects of Hubei Province, China, National Natural Science Foundation of China, Postdoctoral Science Foundation of China

15-Apr-2026

UT Health San Antonio Multispecialty and Research Hospital treats first clinical trial participant in novel cancer study

The University of Texas at San Antonio Health Science Center
Business Announcement

UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.

15-Apr-2026

Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics

Broad Institute of MIT and Harvard
Business Announcement

The Broad Institute’s Cancer Dependency Map Consortium (DMC) is an academic-industry collaboration that has transformed the study of cancer by developing one of the most comprehensive inventories of tumor vulnerabilities. The next stage of the academic-industrial partnership aims to expand beyond cancer vulnerabilities to investigate cancer resistance, surface targets, and high-dimensional readouts.

15-Apr-2026

UTHealth Houston-developed cancer therapy platform takes major step toward clinical translation

University of Texas Health Science Center at Houston
Business Announcement

CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly.

15-Apr-2026

LINC00862–RBM47 positive feedback loop suppresses hepatocellular carcinoma progression

Compuscript Ltd
Peer-Reviewed Publication

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with limited therapeutic options and poor long-term survival. Increasing evidence highlights the regulatory complexity of long non-coding RNAs (lncRNAs) and RNA-binding proteins (RBPs) in HCC progression, yet the mechanistic interplay between these molecules remains incompletely understood

Journal: Genes & Diseases

15-Apr-2026

New imaging tools help cancer researchers see inside living cells

Oregon Health & Science University
Peer-Reviewed Publication

A new study co-led by an Oregon Health & Science University researcher describes a breakthrough in microscopy tools that could dramatically expand how cancer biology labs study the inner workings of living cells.

Journal: Nature Methods
Funder: Howard Hughes Medical Institute, W. M. Keck Foundation, Searle Scholars Program, Beckman Young Investigator Program, Packard Fellowship for Science and Engineering

15-Apr-2026

A molecular movie captures cancer’s great escape from targeted therapy

Institute for Systems Biology
Peer-Reviewed Publication

Researchers at the Institute for Systems Biology (ISB) reveal a darker side of targeted therapy: the same oncogene inhibition that shuts down cancer growth program can also ignite a stress-driven identity switch — revealing an early escape route that may shape the future of cancer treatment.

Journal: Nature Communications
Funder: Andy Hill CARE Fund

15-Apr-2026

New technique maps cancer drug uptake inside living cells

University of Surrey
Peer-Reviewed Publication

A new analytical method could improve how cancer treatments are designed – by allowing scientists to track, for the first time, exactly where inside a living cell a drug accumulates. Researchers from the University of Surrey and King’s College London developed the method, which detects trace amounts of metal inside individual living cells and their internal compartments without the need to kill the cells first.

15-Apr-2026

BRCA gene mutations now implicated in thyroid, bladder, skin, and head and neck cancer

RIKEN
Peer-Reviewed Publication

An international group have discovered associations between pathogenic variants of the BRCA 1 and 2 genes and four types of cancer. Published in ESMO Open, the findings expand the potential for personalized medicine to several cancer types that currently have limited treatment options and poor prognoses.

Journal: ESMO Open

15-Apr-2026

AI identifies early risk patterns for skin cancer

University of Gothenburg
Peer-Reviewed Publication

Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of Gothenburg. Using AI, it is possible to identify small groups within the population that have a significantly higher risk of developing melanoma within five years.